Challenges of Unbundling Childhood Vaccinations: Critiques and Consequences
Public health experts have criticized President Donald Trump's executive order that aims to change childhood vaccinations in the U.S. The order calls for separating combination shots like the MMR vaccine into individual injections and spacing out vaccination appointments. This change would require drugmakers to produce individual vaccines that have not been marketed separately for decades, leading to financial and logistical challenges for parents, health providers, and drug companies.
Unbundling the MMR vaccine and spacing out shots would mean more frequent doctor visits for parents and could strain pediatricians. Studies have shown that combination vaccines increase protection against infectious diseases, and health experts argue that there is no scientific basis for changing the current vaccination schedule. The proposed changes would require significant investments from drugmakers to conduct new studies, build manufacturing facilities, and gain FDA approval for individual vaccines.
Currently, all measles, mumps, and rubella vaccines in the U.S. are combination shots, and companies would need to demonstrate the safety and effectiveness of new individual vaccines. Developing new vaccine plants typically takes about five years, and the FDA would need to review and license each unbundled vaccine separately. Companies like Merck and GSK, which supply childhood vaccines in the U.S., have not announced plans to unbundle their shots.
Splitting the MMR shot into three separate components would result in six office visits for children, increasing the inconvenience and cost for parents. Health experts warn that more visits could lead to missed appointments and lower vaccination rates. Despite Trump's order, experts doubt that drugmakers will develop individual vaccines, as there is little business incentive to compete against their own combination shots. The order is not legally binding, and only state governments have the authority to require vaccinations for schoolchildren.
In conclusion, Trump's executive order to change childhood vaccinations faces significant challenges in implementation and may not lead to meaningful changes in the current vaccination schedule. Experts argue that the proposed changes lack scientific justification and could result in increased costs and lower vaccination rates for children.